Early Findings Show Promise of CAR NK-Cell Therapy in Leukemia, Lymphoma
Patients with either relapsed or refractory non-Hodgkin lymphoma or chronic lymphocytic leukemia treated with CAR NK cells had a response without the development of cytokine release syndrome, neurotoxicity, or graft-versus-host disease.
Source: CancerNetwork - Category: Cancer & Oncology Authors: Hannah Slater Source Type: news
More News: Brain | Cancer & Oncology | Chronic Leukemia | Chronic Lymphocytic Leukemia | Hodgkin's Disease | Leukemia | Lymphoma | Neurology | Non-Hodgkin's Lymphoma